高氨血症
丙戊酸
医学
奎硫平
富马酸奎硫平
内科学
奥氮平
胃肠病学
药理学
精神科
癫痫
非定型抗精神病薬
精神分裂症(面向对象编程)
抗精神病药
作者
Athar Halaby,Ramzi Haddad,Wadih Naja
标识
DOI:10.2174/15748863113089990039
摘要
Introduction: Hyperammonemia is one of the rare nevertheless serious side effects associated with valproic acid treatment. Two cases of valproic acid induced hyperammonemia are detailed in this article. Cases: Case one describes an adult male who developed hyperammonemia after acute exposure to valproic acid as a treatment for his bipolar disorder-manic episode. Case two developed a similar pattern of toxicity but after chronic exposure to valproic acid. Both patients were receiving a combination of valproic acid and quetiapine. Discussion: Measurement of the ammonium level should be considered where there is a decreased level of consciousness in patients receiving valproic acid irrespective of the diagnosis and even after a long term exposure. A possible risk of hyperammonemia can result from a combination of valproic acid and quetiapine, however further studies are yet needed to confirm this hypothesis. Keywords: Hyperammonemia, quetiapine, valproic acid.
科研通智能强力驱动
Strongly Powered by AbleSci AI